Sanofi (SNYNF) Times Interest Earned (2009 - 2026)
Sanofi's (SNYNF) quarterly Times Interest Earned came in at -$11.92 in Q1 2026, down 11.07% year-on-year from -$13.4 in Q1 2025, and down 239.85% quarter-over-quarter from $8.52 in Q4 2025.
Sanofi (SNYNF) Times Interest Earned (2009 - 2026) Analysis & Trends
Sanofi has disclosed Times Interest Earned across 18 years of filings, most recently posting -$11.92 for Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$11.92, down 11.07% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.19 (up 1.45% YoY), and the FY2025 annual result was $11.27, up 66.72% from the prior year.
- Times Interest Earned came in at -$11.92 for Q1 2026 at Sanofi, down from $8.52 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $8.52 in Q4 2025 to a low of -$27.24 in Q1 2022.
- The 5-year median for Times Interest Earned is -$10.1 (2023), against an average of -$10.42.
- Across the five-year window, Times Interest Earned tumbled 132.81% in 2022 and soared 1695.54% in 2025, its largest moves.
- Sanofi's Times Interest Earned stood at -$9.32 in 2022, then surged by 42.28% to -$5.38 in 2023, then surged by 90.08% to -$0.53 in 2024, then surged by 1695.54% to $8.52 in 2025, then tumbled by 239.85% to -$11.92 in 2026.
- The last three Times Interest Earned figures came in at -$11.92 (Q1 2026), $8.52 (Q4 2025), and -$12.55 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 96,436,181.12 Bn | 96,436,176.16 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 1,017.30 Bn | 1,012.01 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 579.61 Bn | 557.55 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 402.30 Bn | 392.96 Bn | 10.78 Bn | - |
| 5 | Merck | 294.24 Bn | 288.59 Bn | 12.09 Bn | - |
| 6 | Amgen | 191.82 Bn | 179.78 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 149.05 Bn | 136.28 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.33 Bn | 105.88 Bn | 8.07 Bn | - |
| 10 | Sanofi | - | - | 9.49 Bn | -11.92 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.92 |
| Dec 31, 2025 | 8.52 |
| Sep 30, 2025 | -12.55 |
| Jun 30, 2025 | -9.96 |
| Mar 31, 2025 | -10.73 |
| Dec 31, 2024 | -0.53 |
| Sep 30, 2024 | -13.88 |
| Jun 30, 2024 | -4.56 |
| Mar 31, 2024 | -5.00 |
| Dec 31, 2023 | -5.38 |
| Sep 30, 2023 | -10.10 |
| Jun 30, 2023 | -9.20 |
| Mar 31, 2023 | -14.66 |
| Dec 31, 2022 | -9.33 |
| Sep 30, 2022 | -26.45 |
| Jun 30, 2022 | -14.18 |
| Mar 31, 2022 | -27.24 |
| Dec 31, 2021 | -4.01 |
| Sep 30, 2021 | -34.85 |
| Jun 30, 2021 | -17.10 |